Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease
Conclusion: Oral ER calcifediol is safe and effective in treating SHPT and vitamin D insufficiency in CKD.Am J Nephrol 2016;44:316-325
Source: American Journal of Nephrology - Category: Neurology Source Type: research
More News: Calcium | Chronic Kidney Disease | Hormones | Hyperparathyroidism | Neurology | Study | Urology & Nephrology | Vitamins